cGxP.wire https://validator.w3.org/feed/docs/rss2.html Antengene Secures China IND Clearance for ATG-201 Harbour BioMed Clears Regulatory Milestone for HBM7004 Sanofi Ends Phase 3 MOBILIZE Trial of Riliprubart in CIDP Argo Biopharma Reports Positive Phase 2 HAE Data for BW-20805 AlzeCure and Eli Lilly Partner on Alzheimer’s Drug ACD680 Kelun-Biotech and Windward Bio Advance SKB378 in COPD Vertanical’s Exilby Wins First European Approval for Chronic Pain RedHill’s Opaganib Gains FDA Rare Pediatric Disease Status Bial Discontinues Pariceract After Phase 2b ACTIVATE Trial Miss Pentixapharm Advances PANDA Phase 3 Study After FDA Clearance PureTech and Seaport Report Positive GlyphAgo Phase 1 Data Novanta Acquires Riverpoint Medical in $1.45 Billion Deal Zai Lab Secures China Approval for TIVDAK in Cervical Cancer insitro Advances AI-Discovered CTRO-1013 for MASH With Anti-Fibrotic Data Pfizer’s HYMPAVZI Gains FDA Approval for Expanded Hemophilia Care GSK to Acquire Nuvalent in $10.6B Lung Cancer Expansion Incyte to Acquire Vega Therapeutics for $2 Billion Deal Spruce Biosciences Reports Six-Year TA-ERT Data in MPS IIIB Thirdwayv Technology Powers FDA-Authorized Glas G2 Platform Neurocrine Biosciences Reports New INGREZZA Data in Tardive Dyskinesia DBV Technologies Reports Positive VITESSE Data for VIASKIN Peanut Patch Waters Launches New Platform for GLP-1 and LNP Analytics JCR Pharmaceuticals Presents New MPS Clinical Data at MPS 2026 Merck and Gilead End KEYNOTE-D46 Study Update IBA Receives FDA Approval for First ConformalFLASH Human Trial Oculis Initiates PREDICT-1 Trial for Licaminlimab in Dry Eye Disease Coya Therapeutics Begins Blinded Extension Phase of ALSTARS Trial for COYA 302 in ALS Engitix and GSK Partner to Advance Liver Fibrosis Drug Discovery Seek Labs Advances Antiviral Discovery with BioSeeker Viral Mapping Milestone Lilly’s Foundayo Outperforms Rivals in Landmark Diabetes Trials MetaVia Unveils Promising ADA 2026 Data for Obesity Pipeline Moderna and Oxford Launch Phase 1/2 Trial of mRNA Cancer Vaccine for Lynch Syndrome Corsair Pharma Showcases Positive Phase 1 TRX-248 Data at PHA 2026 Johnson & Johnson Acquires Firefly Bio to Boost Oncology LENZ Therapeutics and Everest Medicines Partner to Advance VIZZ in Greater China Waters Secures FDA Clearance for BD BACTEC FXI System DarioHealth Data Show 14.3% Weight Loss When Digital Care Is Combined with GLP-1 Therapy Ascletis Showcases ASC30, ASC37 and ASC39 Obesity Data at ADA 2026 Antengene Presents First Preclinical Data for ATG-207 at EULAR 2026 AbbVie Strengthens Blood Cancer Leadership with New EHA 2026 Clinical Findings Vasa Therapeutics Presents New VS-041 Data for HFpEF at ECM2026 IBA Secures Duke Health Deal for Two Proteus®ONE Proton Therapy Systems Galmed to Acquire Colospan in Major GI MedTech Expansion Roche Partners with Nurix to Advance BTK Degrader Bexobrutideg Across Cancer, Immunology and Neurology Neurocrine Presents New INGREZZA Data Showing Rapid Improvements in Tardive Dyskinesia Sanofi Wins EU Approval for Sarclisa SC in Multiple Myeloma Teva Presents New AUSTEDO Data Supporting Sustained TD Treatment Boehringer’s Survodutide Delivers Major Metabolic Benefits AstraZeneca’s Ultomiris Shows Strong IgAN Phase III Results Amphista Therapeutics Receives FDA Clearance for AMX-883 AML Trial